Profound Medical (PROF) Operating Leases (2019 - 2026)

Profound Medical's Operating Leases history runs 8 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Operating Leases rose 2026.47% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 2026.47% increase from a year earlier, with the FY2024 full-year figure at $203000.0, down 59.72% from the prior year.
• Operating Leases rose to $2.9 million in Q1 2026 per PROF's latest filing, from $72000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $2.9 million in Q1 2026 and bottomed at $72000.0 in Q2 2025.
• The 5-year median for Operating Leases is $353500.0 (2023), against an average of $770666.7.
• Across the five-year window, Operating Leases sank 59.72% in 2024 and jumped 2026.47% in 2026, its largest moves.
• Year by year, Operating Leases stood at $817000.0 in 2022, then tumbled by 38.31% to $504000.0 in 2023, then sank by 59.72% to $203000.0 in 2024, then slumped by 64.53% to $72000.0 in 2025, then soared by 3916.67% to $2.9 million in 2026.
• Per Business Quant, the three latest PROF Operating Leases figures stand at $2.9 million (Q1 2026), $72000.0 (Q2 2025), and $136000.0 (Q1 2025).